SinoVac is building a vaccine plant, which it hopes will be ready this year and capable of making up to 100 million shots a year. — Reuters pic
It will start recruiting volunteers this month, it said in a release published on China’s WeChat messaging app platform. Last week, Brazil gave the go-ahead for the company to start testing volunteers in the country. AstraZeneca’s experimental Covid-19 vaccine, which was developed by researchers at the University of Oxford, and Sinopharm are the only other candidates in late-stage Phase III trials.
Phase I and Phase II trials typically test the safety of a drug before it enters Phase III trials that test its efficacy.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: